Dissertation > Excellent graduate degree dissertation topics show

Systemic lupus erythematosus CD4 ~~ CD25 ~~ T cell marker FOXP3 promoter methylation level research

Author: DongJuan
Tutor: LiuXiuMei
School: Shanxi Medical
Course: Internal Medicine
Keywords: Systemic lupus erythematosus CD4~+CD25~+FOXP3~+ regulatory T cells bisulfite sequencing
CLC: R593.241
Type: Master's thesis
Year: 2010
Downloads: 72
Quote: 0
Read: Download Dissertation

Abstract


Objective:1.To investigate the expression of foxp3 on CD4+CD25+regulatory T cell in peripheral blood of patients with systemic lupus erythematosis.2.To investigate the methylation status of the FOXP3 promoter in CD4+CD25+regulatory T cell of patients with systemic lupus erythematosis and its role in the pathogenesis of SLE.Method:The patients with systemic lupus erythematosis (30) and healthy controls (20) were recruited, which include 18 new-onset patients with active SLE (SLEDAI>10) and 12 patients with inactive SLE (SLEDAI<3). The expression of foxp3 CD4+CD25+T cell was analyzed by flow cytometry. The magnetic beads assay was used to isolate the CD4+CD25+T cell. The methylation status difference of the FOXP3 promoter in CD4+CD25+regulatory T cell between patients with SLE and healthy controls was detected by bisulfite-sequencing technology.Results:1. It was showed by flow cytometry that the percentage of CD4+CD25+T cell in patients with active, inactive SLE and controls was 4.8%±08、5.1%±0.7、5.3%±1.0, there was no significant difference in the percentage of CD4+CD25+T cell between SLE patients and healthy controls.2. The percentage of CD4+CD25+FOXP3+T cell in patients with active, inactive SLE and controls was 2.9%±0.6、3.5%±0.6、4.1%±0.9.The percentage of CD4+CD25+FOXP3+T cell in SLE patients were significantly lower than those of healthy controls (p<0.05)3.The percentage of CD4+CD25+FOXP3+T cell in SLE patients shows negative correlations with SLEDAI.4. The methylation status of the FOXP3 promoter-77、-65 site in CD4+CD25+regulatory T cells in patients with active SLE and controls was 33.3%、5%。The methylation status of the FOXP3 promoter in CD4+CD25+regulatory T cells in patients with active SLE was more than those of healthy controls. The results are statistically significant. Though the methylation status of the FOXP3 promoter-137、-126、-113、-58、-43、-15 site in CD4+CD25+regulatory T cells of active SLE patients was more than those of healthy controls, the results are not statistically significant.Conclusion:1. Though there was no significant difference in the percentage of CD4+CD25+T cell between SLE patients and healthy controls, the percentage of CD4+CD25+FOXP3+T cell in SLE patients were significantly lower than those of healthy controls.The down-regulation of Foxp3 expression in the peripheral regulatory Tcells may be involved in SLE.2.There was negtive correlation between SLE disease activity and the percentage of CD4+CD25+FOXP3+T cell in SLE patients. 3.The increase of the methylation status of the FOXP3 promoter-77、-65 site in CD4+CD25+ regulatory T cells in patients may be involved in SLE. The effective interventions for the treatment of SLE can be designed to follow the mechanism, it is a new way of thinking.

Related Dissertations

  1. Clinical Analysis of 33 Cases of Pediatric Systemic Lupus Erythematosus,R725.9
  2. OX40/OX40L peripheral blood lymphocytes in patients with SLE characteristics and biological significance of the expression,R593.241
  3. Changes of the Metalloprotease That Cleaves Von Willebrand Factor in Women During Normal Pregnancy and Other Diseases Like Gestational Hypertension,R714.25
  4. Genetic Variation in CD226 Gene and Systemic Lupus Erythematosus,R593.241
  5. Systemic lupus erythematosus CD4 ~ T cell IL-10 and IL-13 gene methylation status of regulatory sequences,R593.241
  6. Aplication and Development of Cystatin C Kit,R593.241
  7. Analysis on Health-related Quality of Life in Patients with Systemic Lupus Erythematosus,R593.241
  8. The Study of Levels of Toll-like Receptor 9 and IL-10、 IFN-α in Patients with Systemic Lupus Erythematosus,R593.241
  9. The application of the theory of collateral disease in systemic lupus erythematosus,R259
  10. The Effect of AQP4 Deficiency on CD4~+ CD25~+ Foxp3~+ T Regulatory Cells and the Severity of Parkinson’s Disease,R742.5
  11. Left ventricular function in patients with systemic lupus erythematosus ultrasound imaging studies,R445.1
  12. Clinical Observation on the Integrating Treatment of Lupus Nephritis in Mildly or Moderately Active Stage with Traditional Chinese and Western Medicine,R593.242
  13. Clinical Analysis of Renal Injury by Systemic Lupus Erythematosus,R593.241
  14. A Study of the Expression of Lipid Raft/GM1 in Peripheral Blood T Cell and Its Correlation with Cytokines in SLE Patients,R593.241
  15. Level of T-bet, GATA3 and FOXP3 mRNA Expression on the Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus and Its Significance,R593.241
  16. Metabolic Syndrome in Chinese Patients with Systemic Lupus Erythematosus,R593.241
  17. Lupus Decoction Integrative treatment of systemic lupus erythematosus 150 cases of long-term efficacy analysis,R593.241
  18. Study on the Expression Pattern of Histone Demethylases in CD4+T Cells of MRL/1pr Lupus-like Mice,R758.6
  19. Research the Relationship with the Subfamily of Variable Region-βchain of T Cell Receptor and the Clinical Manifestation in Patients with SLE,R593.241
  20. The Clinical Observation of Treating the Acute Stage of Systemic Lupus Erythematosus Which Belongs to the Noxious Heat Type by Xi Jiao Di Huang Tang,R259
  21. 236 Cases of Systemic Lupus Erythematosus Hematological Damage in Patients with Clinical Features and Analysis of Associated Immunological Parameters,R593.241

CLC: > Medicine, health > Internal Medicine > Systemic disease > Autoimmune diseases > Autoimmune diseases, connective tissue disease > Lupus erythematosus > Systemic lupus erythematosus
© 2012 www.DissertationTopic.Net  Mobile